Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27^KIP1

REFERENCES

• Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R.. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489–27494
   PubMed Web of Science ®Google Scholar
• Arai, K. I., Lee, F., Miyajima, A., Miyatake, S., Arai, N., and Yokota, T.. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783–836
   PubMed Web of Science ®Google Scholar
• Biggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., and Arden, K. C.. 1999. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA 96:7421–7426
   PubMed Web of Science ®Google Scholar
• Bouillet, P., Metcalf, D., Huang, D. C., Tarlinton, D. M., Kay, T. W., Kontgen, F., Adams, J. M., and Strasser, A.. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735–1738
   PubMed Web of Science ®Google Scholar
• Boussiotis, V. A., Freeman, G. J., Taylor, P. A., Berezovskaya, A., Grass, I., Blazar, B. R., and Nadler, L. M.. 2000. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6:290–297
   PubMedGoogle Scholar
• Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E.. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868
   PubMed Web of Science ®Google Scholar
• Burgering, B. M., and Coffer, P. J.. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599–602
   PubMed Web of Science ®Google Scholar
• Caldenhoven, E., van Dijk, T., Raaijmakers, J. A., Lammers, J. W., Koenderman, L., and de Groot, R. P.. 1995. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J. Biol. Chem. 270:25778–25784
   PubMedGoogle Scholar
• Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, J. C.. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321
   PubMed Web of Science ®Google Scholar
• Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., Franssen, E., Pritchard, K. I., and Slingerland, J. M.. 1997. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3:227–230
   PubMed Web of Science ®Google Scholar
• Cheng, M., Sexl, V., Sherr, C. J., and Roussel, M. F.. 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091–1096
   PubMed Web of Science ®Google Scholar
• Claret, F. X., Hibi, M., Dhut, S., Toda, T., and Karin, M.. 1996. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383:453–457
   PubMed Web of Science ®Google Scholar
• Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C.. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229–233
   PubMed Web of Science ®Google Scholar
• Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E.. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231–241
   PubMed Web of Science ®Google Scholar
• de Groot, R. P., Coffer, P., and Koenderman, L.. 1998. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 8:12–18
   Google Scholar
• del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G.. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687–689
   PubMed Web of Science ®Google Scholar
• Ezhevsky, S. A., Toyoshima, H., Hunter, T., and Scott, D. W.. 1996. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas. Mol. Biol. Cell. 7:553–564
   PubMed Web of Science ®Google Scholar
• Fujita, E., Jinbo, A., Matuzaki, H., Konishi, H., Kikkawa, U., and Momoi, T.. 1999. Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem. Biophys. Res. Commun. 264:550–555
   PubMed Web of Science ®Google Scholar
• Gronbaek, K., Zeuthen, J., Guldberg, P., Ralfkiaer, E., and Hou-Jensen, K.. 1998. Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood 91:4388–4390
   PubMedGoogle Scholar
• Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., and Unterman, T.. 1999. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274:17184–17192
   PubMed Web of Science ®Google Scholar
• Guthridge, M. A., Stomski, F. C., Thomas, D., Woodcock, J. M., Bagley, C. J., Berndt, M. C., and Lopez, A. F.. 1998. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells 16:301–313
   PubMed Web of Science ®Google Scholar
• Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., and Stokoe, D.. 1998. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol. 8:1195–1198
   PubMed Web of Science ®Google Scholar
• Hengst, L., and Reed, S. I.. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861–1864
   PubMed Web of Science ®Google Scholar
• Hinton, H. J., and Welham, M. J.. 1999. Cytokine-induced protein kinase B activation and Bad phosphorylation do not correlate with cell survival of hematopoietic cells. J. Immunol. 162:7002–7009
   PubMedGoogle Scholar
• Kalejta, R. F., Shenk, T., and Beavis, A. J.. 1997. Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry. Cytometry 29:286–291
   PubMedGoogle Scholar
• Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., and Evan, G.. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544–548
   PubMed Web of Science ®Google Scholar
• Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., and Koff, A.. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721–732
   PubMed Web of Science ®Google Scholar
• Klippel, A., Escobedo, M. A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., and Williams, L. T.. 1998. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol. 18:5699–5711
   PubMed Web of Science ®Google Scholar
• Koenderman, L., Kok, P. T., Hamelink, M. L., Verhoeven, A. J., and Bruijnzeel, P. L.. 1988. An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. J. Leukoc. Biol. 44:79–86
   PubMed Web of Science ®Google Scholar
• Kops, G. J., de Ruiter, N. D., de Vries-Smits, A. M., Powell, D. R., Bos, J. L., and Burgering, B. M.. 1999. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398:630–634
   PubMed Web of Science ®Google Scholar
• Kwon, T. K., Nagel, J. E., Buchholz, M. A., and Nordin, A. A.. 1996. Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene 180:113–120
   PubMedGoogle Scholar
• Lee, J. O., Yang, H., Georgescu, M. M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., and Pavletich, N. P.. 1999. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99:323–334
   PubMed Web of Science ®Google Scholar
• Leevers, S. J., Paterson, H. F., and Marshall, C. J.. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411–414
   PubMed Web of Science ®Google Scholar
• Li, D. M., and Sun, H.. 1998. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. USA 95:15406–15411
   PubMed Web of Science ®Google Scholar
• Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M., and Pagano, M.. 1997. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3:231–234
   PubMed Web of Science ®Google Scholar
• Maehama, T., and Dixon, J. E.. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:13375–13378
   PubMed Web of Science ®Google Scholar
• Mavilio, F., Ferrari, G., Rossini, S., Nobili, N., Bonini, C., Casorati, G., Traversari, C., and Bordignon, C.. 1994. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83:1988–1997
   PubMed Web of Science ®Google Scholar
• Medema, R. H., Herrera, R. E., Lam, F., and Weinberg, R. A.. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289–6293
   PubMed Web of Science ®Google Scholar
• Medema, R. H., Klompmaker, R., Smits, V. A., and Rijksen, G.. 1998. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene 16:431–441
   PubMed Web of Science ®Google Scholar
• Medema, R. H., Kops, G. J., Bos, J. L., and Burgering, B. M.. 2000. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782–787
   PubMed Web of Science ®Google Scholar
• Montagnoli, A., Fiore, F., Eytan, E., Carrano, A. C., Draetta, G. F., Hershko, A., and Pagano, M.. 1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13:1181–1189
   PubMed Web of Science ®Google Scholar
• Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R., and Roberts, J. M.. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570–573
   PubMed Web of Science ®Google Scholar
• Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., and Ruvkun, G.. 1997. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389:994–999
   PubMed Web of Science ®Google Scholar
• Ohtani, M., Isozaki, H., Fujii, K., Nomura, E., Niki, M., Mabuchi, H., Nishiguchi, K., Toyoda, M., Ishibashi, T., and Tanigawa, N.. 1999. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma. Cancer 85:1711–1718
   PubMedGoogle Scholar
• Packham, G., White, E. L., Eischen, C. M., Yang, H., Parganas, E., Ihle, J. N., Grillot, D. A., Zambetti, G. P., Nuñez, G., and Cleveland, J. L.. 1998. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev. 12:2475–2487
   PubMed Web of Science ®Google Scholar
• Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M.. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685
   PubMed Web of Science ®Google Scholar
• Pals, C. M., Verploegen, S. A., Raaijmakers, J. A., Lammers, J. W., Koenderman, L., and Coffer, P. J.. 2000. Identification of cytokine-regulated genes in human leukocytes in vivo. J. Allergy Clin. Immunol. 105:760–768
   PubMedGoogle Scholar
• Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M.. 1997. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 3:222–225
   PubMed Web of Science ®Google Scholar
• Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., and Clurman, B. E.. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1464–1478
   PubMed Web of Science ®Google Scholar
• Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., and Mak, T. W.. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39
   PubMed Web of Science ®Google Scholar
• Takatsu, K.. 1998. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev. 9:25–35
   PubMedGoogle Scholar
• Tang, E. D., Nuñez, G., Barr, F. G., and Guan, K. L.. 1999. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274:16741–16746
   PubMed Web of Science ®Google Scholar
• Toyoshima, H., and Hunter, T.. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74
   PubMed Web of Science ®Google Scholar
• Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H., and Zhang, H.. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661–664
   PubMed Web of Science ®Google Scholar
• Vlach, J., Hennecke, S., and Amati, B.. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:5334–5344
   PubMed Web of Science ®Google Scholar
• Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F.. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241–5248
   PubMed Web of Science ®Google Scholar
• Wang, X.. 1997. p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 15:2991–2997
   PubMed Web of Science ®Google Scholar
• Weber, J. D., Hu, W., Jefcoat, S. C. J., Raben, D. M., and Baldassare, J. J.. 1997. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272:32966–32971
   PubMed Web of Science ®Google Scholar
• White, E.. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1–15
   PubMed Web of Science ®Google Scholar
• Winston, J., Dong, F., and Pledger, W. J.. 1996. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem. 271:11253–11260
   PubMedGoogle Scholar
• Wu, M., Bellas, R. E., Shen, J., Yang, W., and Sonenshein, G. E.. 1999. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J. Immunol. 163:6530–6535
   PubMedGoogle Scholar
• Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., and Sawyers, C. L.. 1998. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 95:15587–15591
   PubMed Web of Science ®Google Scholar